GCS-100

La Jolla dumps its NASH drug and shifts its focus to rare disease
Fierce Biotech
Fri, 05/8/15 - 09:05 am
La Jolla Pharmaceutical
NASH
GCS-100
LJPC-1010
La Jolla Pharma's drug improves kidney function in mid-stage study
Yahoo/Reuters
Mon, 03/10/14 - 05:07 pm
La Jolla Pharmaceutical
GCS-100
chronic kidney disease
4 Small Biotechs With Big Clinical Trials Presenting In 2013
Seeking Alpha
Wed, 01/30/13 - 11:03 am
perifosine
Aeterna Zentaris
Advaxis
GCS-100
La Jolla Pharmaceutical
APPY1
Venaxis
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Enhanced Online News
Sat, 01/21/12 - 05:50 pm
GCS-100
La Jolla Pharmaceutical